In the same line, CD39 blockage with both inhibitor (ARL67156) and antibody (OREG-103/BY40) increased T cells and NK cell-mediate cytotoxicity against SK-MEL-5 melanoma cells (228). This evidence concerns the gene ENTPD1 and melanoma.